Targeting the EGFR in neoplasia--more questions than answers.
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D066246:ErbB Receptors / Q000037:antagonists & inhibitors* / Q000378:metabolism; D006801:Humans; D009363:Neoplasm Proteins / Q000037:antagonists & inhibitors* / Q000378:metabolism; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D004791:Enzyme Inhibitors; D009363:Neoplasm Proteins; D066246:ErbB Receptors; D011505:Protein-Tyrosine Kinases